A detailed history of Cva Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cva Family Office, LLC holds 8,724 shares of BMY stock, worth $500,146. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,724
Previous 7,993 9.15%
Holding current value
$500,146
Previous $331,000 36.25%
% of portfolio
0.07%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$39.66 - $51.75 $28,991 - $37,829
731 Added 9.15%
8,724 $451,000
Q2 2024

Jul 09, 2024

BUY
$40.25 - $52.99 $49,467 - $65,124
1,229 Added 18.17%
7,993 $331,000
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $178,197 - $202,041
3,714 Added 121.77%
6,764 $366,000
Q4 2023

Jan 16, 2024

SELL
$48.48 - $57.85 $24,579 - $29,329
-507 Reduced 14.25%
3,050 $156,000
Q3 2023

Oct 11, 2023

SELL
$57.89 - $64.73 $25,761 - $28,804
-445 Reduced 11.12%
3,557 $206,000
Q2 2023

Jul 10, 2023

BUY
$63.71 - $70.74 $2,866 - $3,183
45 Added 1.14%
4,002 $255,000
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $30,555 - $34,656
-465 Reduced 10.52%
3,957 $274,000
Q4 2022

Feb 21, 2023

SELL
$68.48 - $81.09 $21,023 - $24,894
-307 Reduced 6.49%
4,422 $318,000
Q3 2022

Nov 22, 2022

SELL
$0.13 - $76.84 $54 - $32,426
-422 Reduced 8.19%
4,729 $336,000
Q2 2022

Jul 11, 2022

BUY
$72.62 - $79.98 $18,300 - $20,154
252 Added 5.14%
5,151 $397,000
Q1 2022

Apr 22, 2022

BUY
$61.48 - $73.72 $46,294 - $55,511
753 Added 18.16%
4,899 $358,000
Q4 2021

Jan 25, 2022

BUY
$53.63 - $62.52 $125,655 - $146,484
2,343 Added 129.95%
4,146 $258,000
Q3 2021

Oct 12, 2021

SELL
$59.17 - $69.31 $134,730 - $157,818
-2,277 Reduced 55.81%
1,803 $109,000
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $57,390 - $62,498
927 Added 29.4%
4,080 $273,000
Q1 2021

Apr 14, 2021

BUY
$59.34 - $66.74 $13,232 - $14,883
223 Added 7.61%
3,153 $199,000
Q4 2020

Jan 15, 2021

BUY
$57.74 - $65.43 $65,072 - $73,739
1,127 Added 62.51%
2,930 $181,000
Q3 2020

Oct 27, 2020

BUY
$57.43 - $63.64 $40,947 - $45,375
713 Added 65.41%
1,803 $109,000
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $32,343 - $37,813
590 Added 118.0%
1,090 $64,000
Q1 2020

May 28, 2020

BUY
$46.4 - $67.43 $23,200 - $33,715
500 New
500 $28,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.